Abstract P5-08-02: Real-life analysis evaluating 1594 N0/Nmic breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score result: 5-year KM estimate for breast cancer specific survival with recurrence score results ≤30 is >98%Salomon M. Stemmer, Nicky Liebermann, Shulamith Rizel et al.|Cancer Research|2016Cited by 23